| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 819 | 0 | 819 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| MORGAN STANLEY MED TERM NOTE | 75,000 | 76,500 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| I-SHARES MSCI EMERGING MKT | 60,344 | 94,296 |
| I-SHARES S&P BARRA GROWTH | 146,750 | 279,000 |
| I-SHARES S&P 500 VALUE | 109,004 | 159,409 |
| BARRICK GOLD CORP | 44,930 | 16,125 |
| I SHARES RUSSELL 2000 | 71,590 | 119,620 |
| EDP RENOVAVEIS SA | 58,680 | 39,235 |
| I SHARES LATIN AMERICA 40 | 93,615 | 63,620 |
| I SHARES MSCI CANADA | 52,680 | 57,720 |
| BIOMARIN PHARMACEUTICAL | 60,300 | 90,400 |
| GUARDIAN 8 HOLDINGS | 50,000 | 68,750 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| QCA FIRST FUND IV, LLC | AT COST | 32,646 | 35,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CUSTODIAN FEES | 62 | 62 | 0 | |
| ANNUAL REPORT FILING | 15 | 0 | 15 | |
| NON-DEDUCTIBLE EXPENSES FROM QCA FIRST FUND | 4 | 0 | 0 | |
| ORDINARY LOSS - QCA FIRST FUND IV, LLC | 2,608 | 2,608 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| QCA FIRST FUND IV | 69 | 69 | 69 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| AGENCY & INVESTMENT FEES | 7,371 | 7,371 | 0 | |
| BANK FEES | 8 | 8 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 858 | 858 | 0 |